UF-Led Study Explores Differences in COVID-19 Severity Internationally
The U.S. Centers for Disease Control and Prevention recently awarded a $10 million grant to a team led by Rhoel Dinglasan to test why are some countries in the grip of COVID-19 while others appear less affected.
UF Team Identifies Novel Targets for COVID-19 Antivirals
A multidisciplinary team of researchers at the University of Florida is making progress in their search for targets that could be used for developing treatments for infections with COVID-19. The team posted a paper to bioRxiv reporting the identification of 53 novel genes and pathways that could become druggable targets for antiviral therapies for COVID-19 plus a broad array of coronavirus types.
Inventors Honored at Virtual Standing InnOvation Event
More than 200 innovators participated in a live-stream event and virtual happy hour to celebrate their achievements in fiscal year 2020. The limitations of social gatherings due to the coronavirus pandemic prompted UF Innovate | Tech Licensing to find new ways to honor University of Florida innovators. Instead of an in-person Standing InnOvation, Tech Licensing […]
Harnessing Genome Editing for COVID-19 Drug Discovery
A University of Florida research team is harnessing the power of genomic editing to illuminate druggable targets in human cells for the fight against COVID-19. By taking advantage of high-containment labs in UF’s Emerging Pathogens Institute—especially designed for studying highly contagious and virulent pathogens—the team is using CRISPR genome editing techniques to screen human cell […]
Expert: Outbreak Transmission Dynamics
As the world grapples for answers and action on the new coronavirus outbreak, researchers who study the dynamics of infectious disease outbreaks are quickly digging into the data. It’s familiar territory for Derek Cummings, Ph.D., a professor of biology at the University of Florida’s College of Liberal Arts and Sciences and Emerging Pathogens Institute. Cummings […]